Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 16

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients

Qu, Jiuxin, Cai, Zhao, Duan, Xiangke, Zhang, Han, Cheng, Hang, Han, Shuhong, Yu, Kaiwei, Jiang, Zhaofang, Zhang, Yingdan, Liu, Yang, Bai, Fang, Liu, Yingxia, Liu, Lei, Yang, Liang·2022·Cell & Bioscience

Abstract

Background: COVID-19 pneumonia has caused huge impact on the health of infected patients and associated with high morbidity and mortality. Shift in the lung microbial ecology upon such viral infection often worsens the disease and increases host susceptibility to superinfections. Bacterial superinfection contributes to the aggravation of COVID-19 and poses a great challenge to clinical treatments. An in-depth investigation on superinfecting bacteria in COVID-19 patients might facilitate understanding of lung microenvironment post virus infections and superinfection mechanism. Results: We analyzed the adaptation of two pairs of P. aeruginosa strains with the same MLST type isolated from two critical COVID-19 patients by combining sequencing analysis and phenotypic assays. Both P. aeruginosa strains were found to turn on alginate biosynthesis and attenuate type VI secretion system (T6SS) during short-term colonization in the COVID-19 patients, which results in excessive biofilm formation and virulence reduction-two distinct markers for chronic infections. The macrophage cytotoxicity test and intracellular reactive oxygen species measurement confirmed that the adapted P. aeruginosa strains reduced their virulence towards host cells and are better to escape from host immune clearance than their ancestors. Conclusion: Our study suggests that SARS-CoV-2 infection can create a lung environment that allow rapid adaptive evolution of bacterial pathogens with genetic traits suitable for chronic infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13578-022-00748-z

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 58

  1. Veras FP, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12):e20201129. · DOI · Paper page
  2. Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. · DOI · Paper page
  3. Rawson TM, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–68.
  4. Wang L, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–45. · DOI · Paper page
  5. Cox MJ, et al. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020;1(1):e11. · DOI · Paper page
  6. Sharifipour E, et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis. 2020;20(1):646. · DOI · Paper page
  7. Zhang G, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. · DOI · Paper page
  8. Chen S, et al. Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: an observational study. Clin Respir J. 2021;15(7):815–25. · DOI
  9. Cole SJ, et al. Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect Immun. 2014;82(5):2048–58. · DOI · Paper page
  10. Luyt CE, et al. Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care. 2020;10(1):158. · DOI · Paper page
  11. Wang K, et al. The rapid in vivo evolution of Pseudomonas aeruginosa in ventilator-associated pneumonia patients leads to attenuated virulence. Open Biol. 2017;7(9):170029. · DOI
  12. Marvig RL, et al. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet. 2015;47(1):57. · DOI · Paper page
  13. Smith EE, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA. 2006;103(22):8487–92. · DOI · Paper page
  14. Yang L, et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA. 2011;108(18):7481–6. · DOI · Paper page
  15. Wood TE, et al. The Pseudomonas aeruginosa T6SS delivers a periplasmic toxin that disrupts bacterial cell morphology. Cell Rep. 2019;29(1):187. · DOI
  16. Gysin M, et al. Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland. Ann Clin Microbiol Antimicrob. 2021;20(1):64. · DOI
  17. Qu J, et al. Persistent bacterial coinfection of a COVID-19 patient caused by a genetically adapted Pseudomonas aeruginosa chronic colonizer. Front Cell Infect Microbiol. 2021;11:641920. · DOI
  18. Hentzer M, et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol. 2001;183(18):5395–401. · DOI · Paper page
  19. Qiu D, et al. Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2007;104(19):8107–12. · DOI
  20. Pedersen SS, et al. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun. 1990;58(10):3363–8. · DOI · Paper page
  21. Limoli DH, et al. Pseudomonas aeruginosa alginate overproduction promotes coexistence with Staphylococcus aureus in a model of cystic fibrosis respiratory infection. MBio. 2017;8(2):e00186. · DOI · Paper page
  22. Chattoraj SS, et al. Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice. Infect Immun. 2010;78(3):984–93. · DOI
  23. Limoli DH, Jones CJ, Wozniak DJ. Bacterial extracellular polysaccharides in biofilm formation and function. Microbiol Spectr. 2015;3(3):3. · DOI · Paper page
  24. Malhotra S, Hayes D Jr, Wozniak DJ. Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface. Clin Microbiol Rev. 2019;32(3):e00138. · DOI · Paper page
  25. Mougous JD, et al. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science. 2006;312(5779):1526–30. · DOI · Paper page
  26. Allsopp LP, et al. RsmA and AmrZ orchestrate the assembly of all three type VI secretion systems in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2017;114(29):7707–12. · DOI · Paper page
  27. Hachani A, Wood TE, Filloux A. Type VI secretion and anti-host effectors. Curr Opin Microbiol. 2016;29:81–93. · DOI · Paper page
  28. Ho BT, Dong TG, Mekalanos JJ. A view to a kill: the bacterial type VI secretion system. Cell Host Microbe. 2014;15(1):9–21. · DOI · Paper page
  29. Moscoso JA, et al. The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling. Environ Microbiol. 2011;13(12):3128–38. · DOI · Paper page
  30. Kordes A, et al. Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung. Nat Commun. 2019;10(1):3397. · DOI
  31. Perault AI, et al. Host adaptation predisposes Pseudomonas aeruginosa to type vi secretion system-mediated predation by the Burkholderia cepacia complex. Cell Host Microbe. 2020;28(4):534–47. · DOI
  32. Rossi E, et al. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat Rev Microbiol. 2021;19(5):331–42. · DOI · Paper page
  33. Maes M, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care. 2021;25(1):25. · DOI · Paper page
  34. Gupta S, et al. Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures. Sci Rep. 2021;11(1):3963. · DOI
  35. Bacci G, et al. Untargeted metagenomic investigation of the airway microbiome of cystic fibrosis patients with moderate-severe lung disease. Microorganisms. 2020;8(7):1003. · DOI
  36. Wigen J, et al. Converging pathways in pulmonary fibrosis and Covid-19—the fibrotic link to disease severity. Respir Med X. 2020;2:100023.
  37. Laforge M, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20(9):515–6. · DOI · Paper page
  38. Mason K, et al. COVID-19: pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes. J Clin Transl Endocrinol. 2021;26:100268.
  39. Shekhawat J, et al. Interleukin-6 perpetrator of the COVID-19 cytokine storm. Indian J Clin Biochem. 2021;36(4):1–11. · DOI
  40. Bonfield TL, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2111–8. · DOI · Paper page
  41. Phuong MS, et al. Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response. Cell Death Dis. 2021;12(3):241. · DOI
  42. Kronborg G, et al. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr Pulmonol. 1993;15(5):292–7. · DOI
  43. Yang YW, et al. Pseudomonas aeruginosa ventilator-associated pneumonia induces lung injury through TNF-α/c-Jun NH2-terminal kinase pathways. PLoS ONE. 2017;12(1):e0169267. · doi:10.1371/journal.pone.0169267
  44. Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS ONE. 2010;5(6):e11147. · DOI · Paper page
  45. Larsen MV, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50(4):1355–61. · DOI · Paper page
  46. Zankari E, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–4. · DOI · Paper page
  47. Treangen TJ, et al. The harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 2014;15(11):524. · doi:10.1186/s13059-014-0524-x · Paper page
  48. Bertelli C, et al. IslandViewer 4: expanded prediction of genomic islands for larger-scale datasets. Nucleic Acids Res. 2017;45(W1):W30–5. · DOI · Paper page
  49. Alikhan NF, et al. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics. 2011;12:402. · DOI · Paper page
  50. Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics. 2011;27(7):1009–10. · DOI · Paper page
  51. Winsor GL, et al. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 2016;44(D1):D646–53. · DOI · Paper page
  52. Tatusova T, et al. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016;44(14):6614–24. · DOI · Paper page
  53. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. · DOI · Paper page
  54. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. · DOI · Paper page
  55. Hachani A, Lossi NS, Filloux A. A visual assay to monitor T6SS-mediated bacterial competition. J Vis Exp. 2013;73:e50103.
  56. Jeon YJ, et al. The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform. PLoS ONE. 2014;9(10):e110240. · DOI
  57. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60. · DOI · Paper page
  58. Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):257. · DOI · Paper page

Cited by

See all 16

Metadata

Authors
Qu, J., Cai, Z., Duan, X., Zhang, H., Cheng, H., Han, S., Yu, K., Jiang, Z., Zhang, Y., Liu, Y., Bai, F., Liu, Y., Liu, L., & Yang, L.
Venue
Cell & Bioscience
Published
2022-02-09
Volume
12
Issue
1
ISSN
2045-3701
Cited by
16
References
6
Language
en
Licence
Funders
  • Guangdong Natural Science Foundation for Distinguished Young Scholar (2020B1515020003)
  • Science and Technology Program of Shenzhen (JCYJ20190809144005609)
  • Guangdong Basic and Applied Basic Research Foundation (2020A1515010586)
  • Guangdong Province Science and Technology Project (2020B1111170014)
  • Bill and Melinda Gates Foundation
  • Shenzhen Innovation Committee of Science and Technology (ZDSYS20200811144002008)
  • Shenzhen Science and Technology Program (KQTD20200909113758004)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients. https://app.cochat.ai/papers/10.1186/s13578-022-00748-z
The paper
Qu, J., Cai, Z., Duan, X., Zhang, H., Cheng, H., Han, S., Yu, K., Jiang, Z., Zhang, Y., Liu, Y., Bai, F., Liu, Y., Liu, L., & Yang, L. (2022). Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients. Cell & Bioscience. https://doi.org/10.1186/s13578-022-00748-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.